National Institute of Environmental Health Sciences
VC Fund
Durham, United States
National Institute of Environmental Health Sciences is a VC fund in Durham focused on Biotechnology and Pharmaceutical. National Institute of Environmental Health Sciences conducts research into the effects of the environment on human disease.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 69%
Last updated:
For AI agents: llms.txt
Industries National Institute of Environmental Health Sciences invests in
Stages National Institute of Environmental Health Sciences invests in
Countries National Institute of Environmental Health Sciences invests in
Investment Focus
Industry
- Biotechnology 5 (38%)
- Pharmaceutical 3 (23%)
- Medical 2 (15%)
- Health Care 2 (15%)
- Life Science 2 (15%)
Stage
- Grant 10 (77%)
- Series B 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Interlink Electronics
|
Interlink Electronics focuses on designing and manufacturing cutting-edge human-machine interface (HMI) solutions. The company specializes in advanced sensor technologies, electronic controls, and customized solutions for various industries. Its products enable seamless interaction between humans and machines, delivering precision and reliabilityin dynamic environments. | $280K / Grant / Jul 31, 2025 | |
CLYR.ai
|
CLYR is an advanced air quality intelligence company dedicated to reimagining environmental health monitoring. Its mission of empowering people to reduce environmental exposure. | Grant / Jul 24, 2025 | |
Matter Bio
|
Matter Bio operates as company focus on preserving genome integrity. | Grant / May 29, 2024 | |
ScitoVation
|
ScitoVation is a biotechnology company that provides technical expertise and technology on pharmaceuticals and agricultural chemicals. The company also helps clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products. They develop customized cell-based assays todetermine safety, model chemical disposition in the body, and analyze and interpret genetic data. ScitoVation investigates complex issues, such as chemical modes of action, animal to human exposure extrapolation, and the use of genetic expression and sequencing data to ascertain toxicity. It was founded in 2016 and is headquartered in Durham, North Carolina, USA. | $270K / Grant / Jul 11, 2023 | |
Wayne State University - Mike Ilitch School of Business
|
Wayne State University is a recognized metropolitan research university that offers undergraduate and graduate degree courses.Wayne State's comprehensive academic offerings are divided among 13 schools and colleges: the School of Business Administration; the College of Education; the College of Engineering; the College of Fine,Performing, and Communication Arts; the Graduate School; the Law School; the College of Liberal Arts and Sciences; the College of Library and Information Science; the School of Medicine; the College of Nursing; the Eugene Applebaum College of Pharmacy and Health Sciences; the Irvin D. Reid Honors College; and the School of Social Work. Wayne State University offers more than 370 academic programs through 13 schools and colleges to nearly 29,000 students. Since 1915, Wayne State University has been accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools, one of six regional accrediting agencies in the United States that provides accreditation to colleges and universities at the institutional level.Founded in 1868, Wayne State University is the third largest university in the state of Michigan and one of the 30 largest universities in the United States. | $11.3M / Grant / Sep 08, 2022 | |
GlycoSurf, Inc.
|
GlycoSurf is a specialty chemicals company that was founded in 2013 and produces bio-inspired surfactants (biosurfactants) for a wide range of applications that require specialized surfactants. GlycoSurf's proprietary technology creates rhamnose-containing glycolipids that are high in purity, non-toxic, biodegradable, and chemically tailorable(i.e. rhamnolipids). Rhamnolipids and other biosurfactants are frequently used in the formulation of cosmetic or cosmeceutical personal-care products. | $173.1K / Grant / Jun 09, 2022 | |
Access Sensor Technologies
|
Access Sensor Technologies specialized in environmental diagnostics product research and development. A novel approach to air sampling researchers and industrial hygienists can sample particles for stationary monitoring and personal exposure using the upas. | Grant / Mar 28, 2022 | |
Globin Solutions
|
Globin Solutions, Inc. is a pre-clinical stage biopharmaceutical company that is committed to researching and developing a rapidly acting antidote for carbon monoxide poisoning, the most common human poisoning. Globin intends to aggressively develop its lead compound through preclinical testing with the goal to pursue regulatory clearance forclinical testing. Globin plans to partner with experts in globin chemistry and protein engineering through sponsored research agreements with the University of Pittsburgh to further develop their pipeline of agents for CO poisoning and other indications. | $750K / Grant / Nov 01, 2021 | |
|
Globin Solutions
|
Globin Solutions, Inc. is a pre-clinical stage biopharmaceutical company that is committed to researching and developing a rapidly acting antidote for carbon monoxide poisoning, the most common human poisoning. Globin intends to aggressively develop its lead compound through preclinical testing with the goal to pursue regulatory clearance forclinical testing. Globin plans to partner with experts in globin chemistry and protein engineering through sponsored research agreements with the University of Pittsburgh to further develop their pipeline of agents for CO poisoning and other indications. | $750K / Grant / Nov 04, 2020 | |
Lena Biosciences
|
Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enablescustomers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates). | $252.1K / Grant / Aug 01, 2020 | |
| See all 13 investments → | |||
Co-Investors
National Cancer Institute
1 deal together
National Institutes of Health
1 deal together
National Science Foundation
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does National Institute of Environmental Health Sciences invest in?
National Institute of Environmental Health Sciences invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Grant and Series B stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did National Institute of Environmental Health Sciences last invest?
The most recent investment recorded for National Institute of Environmental Health Sciences closed in Jul 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
